internal carotid artery injury. We investigated whether magnetic resonance angiography (MRA) findings could predict BTO results to thus avoid the use of precautious BTO. This retrospective study, included 96 patients who underwent BTO, eight of whom underwent bilateral BTO. The relationship between the BTO results for 104 internal carotid arteries and the MRA findings obtained in 96 patients were retrospectively evaluated. On MRA, anterior cerebral artery (A1)-anterior communicating artery-A1 was defined as anterior collateral circulation (ACC), and posterior cerebral artery-posterior communicating artery was defined as posterior collateral circulation (PCC). BTO was tolerated in all 27 sides with thick ACC regardless of PCC thickness. In 31 of 44 cases with a thin ACC, the tested sides were BTO-tolerant (70.5%). Of these 44 tested sides, all five with a thick PCC were BTO-tolerant, but eight with a thin PCC and 31 with an invisible PCC showed results other than tolerance. Among cases with an invisible ACC, 10 of 33 tested sides were BTO-tolerant (30.3%). Among these 33 tested sides, outcomes other than tolerance were observed regardless of PCC thickness. Thick, thin, and invisible ACCs were assigned 3, 1, and 0 points, respectively; and thick, thin, and invisible PCCs were assigned 2, 1, and 0 points, respectively. A sum of 3 points in the ACC and PCC indicated that all sides were BTO-tolerant. In conclusion, a thick ACC or a thin ACC with a thick PCC indicates BTO-tolerance. The BTO prediction score is useful for predicting results of BTO.
Introduction
Internal carotid artery (ICA) sacrifice is required to treat parts of giant or blister-like aneurysms. Balloon test occlusion (BTO) is the gold-standard test used to diagnose the risk of cerebral ischemia after ICA sacrifice. [1] [2] [3] BTO is performed not only for cases of planned ICA sacrifice but also for cases with intraoperative ICA injury to confirm collateral flow. 3, 4) Therefore, precautious BTO is sometimes performed in high-risk cases of intraoperative ICA injury before surgery for invasive skull base tumors. 5, 6) BTO is an invasive test with reported complication rates of 3.2-3.7% in large series. 7, 8) Although other noninvasive tests can be used to predict the results of BTO, alternative non-invasive tests for BTO have not been reported. The aim of this study was to investigate whether magnetic resonance angiography (MRA) findings can predict the results of BTO.
Materials and Methods

Study design and patients
This retrospective study was approved by the Institutional Review Board of Toranomon Hospital (No. 1465). Between January 2011 and March 2017, 99 patients underwent BTO at Toranomon Hospital. However, three of these 99 patients were excluded because the ICA was still occluded by tumor invasion in one patient, one patient had moyamoya disease, and the BTO procedure was terminated due to ICA spasm in the remaining patient. Therefore, 96 cases were included in this study. In addition, eight patients underwent BTO of both ICAs. One patient underwent BTO and then subsequent ICA sacrifice under general anesthesia. However, this patient was included because the clinical results of BTO were obtained after ICA sacrifice.
Twenty-six men and 70 women were included, with an age range of 19-90 years (median 57 years). Of these patients, 62 underwent preoperative BTO for invasive pituitary adenomas, 20 underwent BTO for ICA aneurysms, nine underwent BTO for parasellar meningiomas, and five underwent BTO for parasellar tumors.
The relationship between the BTO results obtained in 104 ICAs and the MRA findings obtained in 96 patients were retrospectively evaluated.
BTO procedure
Balloon test occlusion was performed using Allura Xper (Philips Healthcare, Best, The Netherlands) under local anesthesia without sedation. A 5-Fr sheath was placed in the right common femoral artery, and a 4-Fr sheath was placed in the right radial artery. Intravenous heparin was administered to maintain an activated clotting time greater than 250 s during the procedure. After diagnostic angiography of both the ICA and the unilateral vertebral artery, a 5-Fr guide catheter was placed into the ICA of the test occlusion. A balloon catheter (HyperForm 7 × 7 mm; ev3, Medtronic, Santa Rosa, CA, USA) was advanced through the guide catheter into the petrous portion of the tested ICA. After inflation of the balloon, complete occlusion was confirmed by angiography. The patient underwent a continuous neurologic evaluation throughout the examination.
In the presence of a change in neurologic status, the balloon was immediately deflated, and the procedure was terminated. The ICA was occluded for up to 20 min or more. After ICA test occlusion, aortography was performed with a 4-Fr pigtail catheter to assess the venous phase delay between the occluded hemisphere and the contralateral hemisphere. About 30 mL of iodine contrast medium was injected at an injection speed of 10 mL/s for aortography. Selective angiography of the ICA and external carotid artery of the opposite side, the common carotid artery of the tested side and the unilateral vertebral artery was performed after aortography in a subset of patients. Follow-up intracranial angiography through the guide catheter was performed after deflation of the balloon to rule out ischemic complications. Heparin was reversed using protamine sulfate before the sheath was withdrawn.
Diagnostic criteria of BTO
Ischemic tolerance during BTO occlusion was evaluated through neurological symptoms and angiographic findings. Patients who exhibited any neurological symptoms (consciousness disturbance, focal neurological deficits) were diagnosed as BTO intolerant (intolerant group). In the absence of neurological symptoms during 20 min of BTO, patients with a delayed opacification of cortical veins (venous phase delay) of 2 s or greater on the tested side compared with that on the contralateral side were diagnosed as BTO intolerant (venous delay group). Patients who exhibited no neurologic symptoms during BTO and a venous phase delay <2 s on the tested side were diagnosed as BTO tolerant (tolerant group).
Evaluation of MRA findings
Magnetic resonance angiographies were acquired using a 1.5-T MRI (1.5T MAGNETOM Symphony, Siemens Healthcare, Erlangen, Germany and 1.5T Excelart Vantage Power Plus, Toshiba Medical Systems, Tokyo, Japan) or a 3.0-T MRI (3.0T Ingenia, Philips Healthcare) system. MRAs were independently reviewed by a neurosurgeon (N Fukuhara) and a neurointerventionist (H Hosoo). A linear weighted k coefficients were used to evaluate the inter-observer agreement for MRA. Statistical analysis was performed using IBM SPSS Statistics version 21.0 (IBM Corp., Armonk, NY, USA). The thicknesses of the bilateral anterior cerebral artery (A1) segments of the A1, the anterior communicating artery (ACOM), the posterior cerebral artery (P1) segment of the P1 of the tested side, and the posterior communicating artery (PCOM) of the tested side were independently evaluated on MRA. Each vessel was placed in one of three groups based on the narrowest part of each segment: thick (>1 mm on MRA), thin (<1 mm on MRA), and invisible. A1-ACOM-A1 was defined as the anterior collateral circulation (ACC), and P1-PCOM was defined as the posterior collateral circulation (PCC). The ACC and PCC were respectively defined as thick if all segments were thick, they were defined as thin if any segment of the ACC or PCC was thin and not invisible, and they were defined as invisible if any segment of the ACC or PCC was invisible ( Fig. 1 ). A hypoplastic ICA or bilateral vertebral or basilar artery on MRA was not observed in any patient in this study.
Results
Correlations between BTO and MRA findings
The MRA findings of 96 patients were as follows: 84 patients (87.5%) had thick bilateral A1s, six patients (6.3%) had a thick unilateral A1 and a thin contralateral A1, and six patients (6.3%) had a thick unilateral A1 but an invisible contralateral A1. The ACOM was thick in 35 patients (36.4%), thin in 36 patients (37.5%), and invisible in 25 patients (26.0%). These results defined the ACC as thick in 26 patients (27.1%), thin in 39 patients (40.6%), and invisible in 31 patients (32.3%). The PCC of 104 tested ICA sides was thick on 15 sides (14.4%), thin on 20 sides (19.2%), and invisible on 69 sides (66.3%). For the relationship between PCC and the results of BTO, the results were as follows. Among cases with thick PCC on MRA, 12 of the 15 tested sides were tolerant (80.0%), and three exhibited venous delay (20.0%). Among cases with thin PCC on MRA, 17 of the 20 tested sides were tolerant (85.0%), two exhibited venous delay (10.0%), and one was intolerant (5.0%). Among cases with invisible PCC on MRA, 39 of the 69 tested sides were tolerant (56.5%), 14 exhibited venous delay (20.3%), and 16
were intolerant (23.2%). These results indicated that it is impossible to predict the results of BTO using only the thickness of the PCC on MRA. However, the ratio of intolerant cases decreased in proportion to the thickness of the PCC on MRA.
BTO prediction score
Based on these results, we proposed the new scoring system to predict the results of BTO from MRA findings. Thick, thin, and invisible ACC were assigned 3, 1, and 0 points, respectively, and thick, thin, and invisible PCC were assigned 2, 1, and 0 points, respectively. The sum of the points for the ACC and PCC represents the BTO prediction score. All 32 sides of BTO (30 patients) with >2 points were tolerant. Fourteen BTO-tested sides with 2 points (14 patients) included 10 patients in the BTO-tolerant group (71.4%) and four patients exhibiting venous delay (28.6%), but no intolerant patients. Thirty-five BTO-tested sides with 1 point (32 patients) included 21 patients in the BTO-tolerant group (60%), seven patients exhibiting venous delay (20%), and seven patients in the BTO-intolerant group (20%). Twenty-three sides tested with BTO with 0 point (22 patients) included five patients in the BTO-tolerant group (21.7%), eight patients exhibiting venous delay (34.8%), and 10 patients in the BTO-intolerant group (43.5%). The patient with a BTO prediction score >2 points did not require precautious BTO, as all patients were regarded as tolerant. The patient with a BTO prediction score of <2 points was considered high risk because this group included intolerant cases. Summaries of the BTO results using this scoring system are shown in Tables 2 and 3 . The sensitivity, specificity, and accuracy to predict BTO tolerability for each BTO prediction score are set for the indicated cut-off values. Sensitivity is 100% when the cut-off of the BTO prediction score is ≥3 because all these patients tolerated BTO. BTO: balloon test occlusion. were the same in four cases (tolerated in three and venous delay in one). The main collateral flow of these patients was through the ACC. The results of bilateral BTO differed among the other four cases. The discrepancies in the results of bilateral BTO were due to differences in blood flow through the PCC. In particular, the MRA findings of both PCOMs were equal (undetectable) in two of these four cases, although the findings differed in the other two cases.
ICA sacrifice cases
Eight patients underwent ICA sacrifice. Three of the four patients who were BTO-tolerant exhibited no neurological symptoms after ICA sacrifice (their BTO prediction scores were 1, 2 and 3); however, one patient who was BTO-tolerant underwent highflow bypass after ICA sacrifice because the patient exhibited a decrease in cerebral blood flow on single photon emission computed tomography (SPECT) without a deterioration in neurological symptoms (the BTO prediction score was 1). The decrease in cerebral blood flow seemed to be caused by shower embolization that occurred during internal trapping of the ICA. Cross flow was sufficient during BTO performed in the same session. A final angiogram performed after trapping demonstrated delayed washout of contrast in the distal branches in the territory of the MCA. High-flow bypass was performed to prevent further ischemic complications. Two of three patients with venous delay in BTO (the BTO prediction scores were 0 and 1) and one patient who was BTO intolerant (the BTO prediction score was 1) underwent bypass when the ICA was sacrificed. However, one of three patients with venous delay in BTO (the BTO prediction score was 0) exhibited no neurological symptoms without bypass.
Selective angiography during BTO
During ICA balloon occlusion, selective angiography of the common carotid artery and the unilateral vertebral artery in addition to aortography was performed in 84 tested ICAs of 78 patients (six patients underwent bilateral selective angiography). BTO of these 84 ICA sides was tolerated in 65 sides of 63 patients, resulted in venous delay in 18 sides of 18 patients, and was intolerable in one side.
Cross-flow through the ACC was observed in all 27 sides tested with BTO (100%) with thick ACC on MRA, in 33 of 34 sides (97.1%) with thin ACC on MRA, and in 13 of 23 sides (56.5%) with invisible ACC on MRA. Cross-flow through the PCC was observed in all 15 sides tested with BTO (100%) with thick PCC on MRA, in 13 of 19 sides (68.4%) with thin PCC on MRA, and in 25 of 50 sides (50.0%) with invisible PCC on MRA. In addition, cross-flow through the ophthalmic artery was observed in 30 of 84 sides tested with BTO. Moreover, the main cross-flow was through the ophthalmic artery in one BTO-tested side in a patient with invisible ACC and invisible PCC on MRA. These results are summarized in Table 4 .
BTO of bilateral ICAs
Among the eight cases in which BTO was performed on the ICA of both sides, the results of bilateral BTO Neurol Med Chir (Tokyo) 59, October, 2019
Complications
No serious complications were observed in any cases of BTO. Transient hypotension after BTO was observed in three patients, and vomiting after BTO was observed in one patient. Arterial dissection treated with observation alone was observed in two patients upon diagnostic angiography immediately prior to BTO.
Discussion
In skull base tumor or head and neck tumor surgeries involving the ICA, ICA sacrifice is sometimes required for gross total tumor resection or due to intraoperative ICA injury. In these high-risk cases, BTO is preoperatively performed to evaluate cerebral cross-flow. However, ICA sacrifice is not performed in all patients who preoperatively undergo BTO. In previous studies on preoperative BTO, BTO was performed for high-risk patients with ICA occlusion; however, the ICA was sacrificed in only a subset of the patients. 6, 9) In our institution, BTO is frequently performed, especially for invasive skull base tumors, although only 10% of patients undergo practical ICA sacrifice. The other 90% of patients undergo precautious BTO when ICA sacrifice is emergently required. Nevertheless, omitting precautious BTO is preferred if possible to avoid complications and to reduce costs. Most previous BTO studies have investigated the accuracy of BTO, [10] [11] [12] [13] although one study examined the correlation between the results of BTO and Matas/Allcock tests. 14) No studies have reported a correlation between the results of BTO and MRA. MRA is a non-invasive test that is relatively inexpensive and widely available. Therefore, predicting the results of BTO by MRA would be very useful.
This study indicates that it is possible to omit precautious BTO when MRA reveals thick ACC or thin ACC with thick PCC (BTO prediction score >2). However, other variations are associated with BTO intolerance or venous delay. Therefore, BTO should be performed for high-risk patients with ICA injury when MRA shows other variations, especially if both the ACC and PCC are invisible or if one is thin and the other is invisible (BTO prediction score <2) because it is difficult to predict the results of BTO. These results indicate that ACC cross-flow is important in the context of ICA occlusion. PCC cross-flow appears to be only supportive, as thick PCC was not always indicative of BTO tolerance. The thickness of the PCC is also related to ischemic tolerance during BTO because the intolerance rate increased in cases with thin or invisible PCC.
A good BTO prediction score indicates that the vessels of the ACC and PCC are thicker and that collateral cross-flow is richer. Low blood flow and angiostenosis are known to be overestimated on MRA compared with angiography. Therefore, a thick vessel on MRA may indicate sufficient blood flow on angiography, which would be consistent with the judgment of a clinician, so this scoring system is easy to understand and apply in clinical practice. All cases with a BTO prediction score >2 showed tolerance on BTO, meaning that precautious BTO can be avoided even in high-risk patients with ICA injury. Cases with a BTO prediction score <2 included BTO-intolerant patients, so this group includes patients with a high risk for ICA sacrifice. In addition, fewer tolerant patients and more intolerant patients were found to have BTO prediction scores of 0 rather than 1. Collateral cross-flow through the ACC or PCC was especially minimal in patients with invisible ACC and PCC on MRA. The patients with a BTO prediction score of 2 included patients exhibiting venous delay, but no intolerant patients. Whether precautious BTO should be omitted in this group is controversial, as the absence of symptoms but the presence of venous delay on BTO does not always imply ischemic tolerance.
In this study, a venous phase delay >2 s without neurological symptoms was diagnosed as insufficient cross-flow. It was previously reported that a venous delay >2 s on BTO corresponded to a high risk of ischemic complications after ICA sacrifice, although BTO was performed under general anesthesia in this report. 15) Although one of four patients in this study in the BTO-tolerant group exhibited decreased cerebral blood flow (CBF) on SPECT after practical ICA sacrifice, the decreased CBF was seemed to be caused by shower embolization that occurred during internal trapping of the ICA. Therefore, this does not deny the reliability of the diagnostic criteria of BTO. However, the criteria for venous phase delay vary among reports, and ischemic tolerance with ICA occlusion was not associated with venous phase delay in a recent report. 12, 16, 17) It has been reported that SPECT, positron emission tomography (PET), electroencephalogram, and stump pressure were used in combination for evaluating ischemic tolerance in BTO. [11] [12] [13] [17] [18] [19] [20] It is clear that a patient exhibiting neurological symptoms during BTO would not be tolerant to ischemia after ICA sacrifice. However, whether a patient with a venous phase delay on BTO will show ischemic tolerance remains controversial. Emergent ICA sacrifice is required if intraoperative ICA injury occurs. Patients with venous phase delay on BTO may have some risk of comprehensive cerebral ischemia immediately after ICA sacrifice, although no such symptoms were found during BTO. These ischemic complications can be caused by factors that are not evaluated during BTO, such as hypotension. Therefore, precautious BTO could not be avoided in our venous delay or tolerant group; however, one patient who exhibited venous delay on BTO had no neurological symptoms after ICA sacrifice was performed without bypass.
In some cases, cross-flow was confirmed on selective angiography even if vessels were invisible on MRA. Therefore, patients with an invisible ACOM and/or PCOM on MRA should not be diagnosed as BTO intolerant.
Four of the eight patients who underwent bilateral BTO exhibited consistent results on the left and right sides. The results mainly differ depending on blood flow from the PCOM. In addition, collateral flows through the ophthalmic artery or leptomeningeal anastomosis may also influence the differences in the results of bilateral BTO. Therefore, BTO should be performed for bilateral ICAs if necessary. It was not possible to predict the results of BTO based on the results of the opposite side.
A limitation of this study was the small number of patients for some variations of MRA findings. It is difficult to evaluate collateral flows through the ophthalmic artery or leptomeningeal anastomosis by MRA and to incorporate influences of these collateral flows into a BTO prediction score. In this study, the thickness of each vessel was categorized as one of three types. The vessel thickness was not defined by strict size because the MRI model (1.5 or 3.0T) or setting of each institute can affect the MRA findings and result in discrepancies. The interpretation of thickness is likely different for each physician. However, for application in actual clinical practice, using detailed definitions is difficult. Therefore, in this study, blood vessel thickness was simply divided into three categories. In addition, duplicate results were included for the eight patients who underwent bilateral BTO, although these patients constituted a small proportion of the entire patient sample. By increasing the number of patients, it may be possible to more clearly differentiate between cases that do or do not require BTO to avoid complications due to unnecessary BTO. Therefore, BTO should be omitted only for a certain group of patients who exhibit tolerance, as the ischemic complications of ICA sacrifice are severe. In addition, precautious BTO should only be performed when necessary, although the risk of serious complications with BTO was low in this study.
Conclusion
Some MRA findings can predict the results of BTO in a subset of cases. Thick or thin ACC with thick PCC on MRA indicated tolerance of BTO. In these cases, BTO can be omitted. Our new "BTO prediction score" is useful for predicting the results of BTO.
